Emyria, a company focused on developing innovative treatments for mental health and neurological conditions, said its CFO Joseph Ohayon has resigned.

Simon Kemp has been appointed general manager of clinical operations. Kemp brings extensive experience in founding, scaling, and growing clinical services to Emyria.

Kemp previously co-founded Sleep Studies Australia, where he expanded services nationally and grew annual revenue to $3.5 million.